• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Lupin launches Mycophenolate Mofetil Tablets USP

expresspharmaDecember 30, 2020

Tag: lupin , Mycophenolate Mofetil tablets , ANDA

Lupin announced the launch of Mycophenolate Mofetil Tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech received approval for its ANDA from the United States Food and Drug Administration.

Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept Tablets of Roche Palo Alto, indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, and should be used in combination with other immunosuppressants.

Mycophenolate Mofetil Tablets USP   (RLD:   CellCept) had an annual sales of approximately $87 million in the US. (IQVIA MAT October 2020).

Previous:Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes

Next:AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Lupin launches Mycophenolate Mofetil Tablets USP | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

High Quality Standard Natural Health Supplement Citrus Paradisi Extract 98% Naringin Powder

High Quality Standard Natural Health Supplement Citrus Paradisi Extract 98% Naringin Powder
C 6000 global standards Package 1/10

C 6000 global standards Package 1/10
sandalwood oil

sandalwood oil
High standard and safety Human Immunoglobulin without preservatiivesand antibiotics

High standard and safety Human Immunoglobulin without preservatiivesand antibiotics
High standard and safety Hualan Human Prothrombin Complex without preservatives

High standard and safety Hualan Human Prothrombin Complex without preservatives
CP/EP standard 95% up Fosfomycin Sodium/ Disodium phosphonomycin 26016-99-9

CP/EP standard 95% up Fosfomycin Sodium/ Disodium phosphonomycin 26016-99-9
Lupeol-8%-Lupinus Albus Extracts

Lupeol-8%-Lupinus Albus Extracts
Water standard 5 mg/ml - (Water standard 5 mg/ml)

Water standard 5 mg/ml - (Water standard 5 mg/ml)
Ginkgo biloba dry standard extract (EGb 761)

Ginkgo biloba dry standard extract (EGb 761)
Fully automatic standard PFS injection pen

Fully automatic standard PFS injection pen

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service